LGALS1 and neoplasm: Using a Wilcoxon test, the expression of galectin-1 and integrin α5β1 in tumor cells was significantly decreased in postchemotherapy samples compared with prechemotherapy tissue samples, respectively (P<0.05) (Table 2).